Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma
Clinical trial NCT07018050 · RECRUITING
Trial details
- NCT number
- NCT07018050
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-12
- Primary completion
- 2027-11-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.